Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives
Recruitment status was: Not yet recruiting
Parkinson Disease is one of the most common neurodegenerative illnesses. First degree relatives of Parkinson patient are in high risk for developing the disease. We will try to detect early changes in brain metabolism before the appearance of Parkinson symptoms.
Participants: first degree relatives of diagnosed Parkinson patients that carry a gene mutation in either LRRK2 or GBA genes.
The examination results will be given to the participants by a doctor from the neurology department.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
Please refer to this study by its ClinicalTrials.gov identifier: NCT01089270
|Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center|
|Tel Aviv, Israel|
|Principal Investigator:||Einat Even-Sapir, MD, PhD||Tel Aviv Sourasky Medical Center, Tel Aviv, Israel|